sr 33557 has been researched along with 1,4-dihydropyridine in 1 studies
Studies (sr 33557) | Trials (sr 33557) | Recent Studies (post-2010) (sr 33557) | Studies (1,4-dihydropyridine) | Trials (1,4-dihydropyridine) | Recent Studies (post-2010) (1,4-dihydropyridine) |
---|---|---|---|---|---|
50 | 3 | 1 | 1,115 | 23 | 221 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fraser, S; Kenny, BA; Spedding, M | 1 |
1 other study(ies) available for sr 33557 and 1,4-dihydropyridine
Article | Year |
---|---|
Identification of a novel calcium antagonist binding site in rat brain by SR 33557.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Binding Sites; Calcium Channel Blockers; Cations, Divalent; Cations, Monovalent; Cecum; Cerebral Cortex; Dihydropyridines; Female; Guinea Pigs; Indolizines; Male; Muscle Contraction; Muscle, Smooth; Phenethylamines; Rats; Rats, Sprague-Dawley | 1993 |